Stock listing
896047 Stock Price, News, Filings & Events — Biocryst Pharmaceuticals, Inc.
Selected listing: 896047 · LSX · EUR · DE
This page tracks Biocryst Pharmaceuticals, Inc.'s 896047:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 896047:LSX. 896047:LSX is the stock-level entry point for investors researching Biocryst Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. The company has a market capitalization of approximately $2.37 billion. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.
- Ticker
- 896047:LSX
- Asset type
- Stock
- Market cap
- $2.44B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Biocryst Pharmaceuticals, Inc. 896047:LSX stock context
This page tracks Biocryst Pharmaceuticals, Inc.'s 896047:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 896047:LSX. 896047:LSX is the stock-level entry point for investors researching Biocryst Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biocryst Pharmaceuticals, Inc. (BCRX) is a public company based in the United States, specializing in the development of innovative therapies for rare diseases. The company has a market capitalization of approximately $2.37 billion. Biocryst focuses on creating treatments that address unmet medical needs, leveraging its expertise in biopharmaceuticals.
Latest news from Biocryst Pharmaceuticals, Inc.
BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan
August 25, 2026
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
August 14, 2026
BioCryst Reports Second Quarter 2026 Financial Results
August 5, 2026
BioCryst to Report Second Quarter 2026 Financial Results on August 5
July 22, 2026
BioCryst Appoints David W. Jenkins as Chief Scientific Officer
July 15, 2026
Research Biocryst Pharmaceuticals, Inc.
Biocryst Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for 896047:LSX.
Biocryst Pharmaceuticals, Inc. company profile
View the public company page for Biocryst Pharmaceuticals, Inc. on 6ix.
Biocryst Pharmaceuticals, Inc. news
Read company news and market updates connected to Biocryst Pharmaceuticals, Inc..
Biocryst Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Biocryst Pharmaceuticals, Inc..
Alternate listings
BCRX:NASDAQ
US · USD
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BO1:TRADEGATE
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BO1:GETTEX
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BCRX:BMV
MX · MXN
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
896047:LS
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BO1:FWB
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BCRX:BIVA
MX · MXN
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BCRX:BOATS
US · USD
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BO1:SWB
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BO1:DUS
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BO1:MUN
DE · EUR
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.
BO1:BX
CH · CHF
Alternate listing for Biocryst Pharmaceuticals, Inc.; the primary context on this page is 896047:LSX.